Evaluation of the Pharmacokinetic Interaction Between PA-824 and Midazolam

NCT01768273 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

14

Enrollment

OTHER

Sponsor class

Conditions

Tuberculosis

Interventions

DRUG: Midazolam
DRUG: PA-824

Sponsor

Global Alliance for TB Drug Development